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An African Salmonella Typhimurium
ST313 sublineage with extensive drug-resistance
and signatures of host adaptation
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Bloodstream infections by Salmonella enterica serovar Typhimurium constitute a major health
burden in sub-Saharan Africa (SSA). These invasive non-typhoidal (iNTS) infections are
dominated by isolates of the antibiotic resistance-associated sequence type (ST) 313. Here,
we report emergence of ST313 sublineage II.1 in the Democratic Republic of the Congo.
Sublineage II.1 exhibits extensive drug resistance, involving a combination of multidrug
resistance, extended spectrum β-lactamase production and azithromycin resistance. ST313
lineage II.1 isolates harbour an IncHI2 plasmid we name pSTm-ST313-II.1, with one isolate also
exhibiting decreased ciproﬂoxacin susceptibility. Whole genome sequencing reveals that
ST313 II.1 isolates have accumulated genetic signatures potentially associated with altered
pathogenicity and host adaptation, related to changes observed in bioﬁlm formation and
metabolic capacity. Sublineage II.1 emerged at the beginning of the 21st century and is
involved in on-going outbreaks. Our data provide evidence of further evolution within the
ST313 clade associated with iNTS in SSA.
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S almonella enterica subspecies enterica serovar Typhimur-ium (S. Typhimurium) and other non-typhoidal Salmo-nella are common causes of gastrointestinal infections in
people living in industrialized countries. However, in sub-Saharan
Africa (SSA), invasive non-typhoidal Salmonella (iNTS) blood-
stream infections are common1,2 totalling ~3.4 million cases
annually, with S. Typhimurium being responsible for approxi-
mately two-thirds of these cases. The fatality rate in iNTS can be
extremely high3.
In SSA, iNTS patients often do not suffer from diarrhoea but
instead display symptoms of fever and septicaemia4. There has
been no proven zoonotic source of ST313 infections, and human
to human transmission has been postulated5,6. The disease dis-
proportionately affects children under 5-years old and human
immunodeﬁciency virus (HIV) positive adults7.
Whereas the majority of S. Typhimurium associated with
gastroenteritis in developed countries belong to sequence types
(ST) 19 and 34, S. Typhimurium iNTS in SSA are predominantly
of ST3138. The population structure of S. Typhimurium ST313 is
dominated by two clonal lineages, named I and II, that sequen-
tially spread across SSA over the past 40 years. The success of
these ongoing pandemics has been attributed to resistance to
antibiotics and the emergence of HIV9. The majority of iNTS S.
Typhimurium isolated in the past 10 years have been of ST313
lineage II10–12.
S. Typhimurium ST313 isolates are predominantly multidrug
resistant (MDR), implying co-resistance to the three former ﬁrst
line antibiotics ampicillin, trimethoprim/sulfamethoxazole and
chloramphenicol13,14. Two recent genomics-based studies
reported the acquisition of extended-spectrum β-lactamases
(ESBLs) conferring resistance to the third generation cephalos-
porin ceftriaxone among S. Typhimurium ST313 lineage II iso-
lates from Malawi and Kenya10,11. Ceftriaxone is a recommended
antibiotic to treat complicated iNTS, while the ﬂuoroquinolone
ciproﬂoxacin is recommended for uncomplicated iNTS15.
The genomes of S. Typhimurium ST313 show evidence of
specialization towards a narrow host range by pseudogenization
in a pattern that resembles that found in the host restricted
typhoidal Salmonella enterica subspecies enterica serovar Typhi
(S. Typhi)4,16,17. The genotypic differences between ST313 and
ST19 isolates have been conﬁrmed as phenotypes associated with
host virulence and other traits, including bioﬁlm formation which
has been postulated to inﬂuence both survival in the environment
and macrophages9,18–22.
Here, we report the emergence of an extensively drug resistant
(XDR) ST313 sublineage we name II.1, which is currently causing
bloodstream infections in the Democratic Republic of the Congo
(DRC) and represents >10 % of all S. Typhimurium isolated in
the Kongo Central Province14. This sublineage is associated with
a combination of MDR, ESBL production and resistance to azi-
thromycin (AZI). Additionally, whole-genome sequencing of
multiple genomes identiﬁes signatures associated with patho-
genicity, metabolism and potentially host adaptation.
Results
An XDR S. Typhimurium ST313 sublineage II.1 is emerging.
Invasive S. Typhimurium have been isolated in various hospital
sites across DRC during ongoing microbial surveillance of
bacterial bloodstream infections14,23,24. As third-generation
cephalosporins and AZI have been used in treatment, we have
monitored susceptibility using both phenotypic and genetic
approaches. Consequently, to investigate the emerging phenotype
of ESBL production and AZI resistance, a selection of 81 S.
Typhimurium isolates from the region were subjected to whole-
genome sequence analysis. Their year and place of origin, the age
of the patient and their phenotypic antimicrobial susceptibility
are listed in Supplementary Data 1. Of this panel, 54 S. Typhi-
murium isolates exhibited AZI resistance and were ESBL positive;
all except three were also MDR and are thus classiﬁable as XDR.
The isolates were collected from 2008 to 2016 in western
(Kisantu, Kongo Central Province n= 50; Kinshasa n= 2) and
north-eastern DRC (Kisangani, Tshopo Province: n= 2) (Fig. 1).
Minimum inhibitory concentration (MIC) values for AZI resis-
tance were between 32 and >256 mg L−1. Two of these isolates,
5390_4 (Kisangani, 2016) and 2735 (Kinshasa, 2008), showed
decreased susceptibility to the ﬂuoroquinolone ciproﬂoxacin
(decreased ciproﬂoxacin susceptibility (DCS), MIC values of 0.38
and 0.19 mg L−1against ciproﬂoxacin, respectively). These isolates
also exhibited resistance to the quinolone peﬂoxacin, and sus-
ceptibility (5390_4) or resistance (2735) to the quinolone
nalidixic acid. The other 27 S. Typhimurium isolates form a
representative local context, originating from bloodstream infec-
tions in the same surveillance sites in DRC (see Supplementary
Note 1). They were isolated between 2007 and 2016, and showed
no ESBL production nor resistance to AZI. The majority of these
isolates (22 out of 27) were MDR. One isolate, 16755_3 (Kisantu,
2016), exhibited DCS with a MIC value of 0.19 mg L−1.
Multilocus sequence typing (MLST) conﬁrmed that all belong
to ST313. To provide context for the genomic analysis, 153
African9,11,12,25,26 and 42 non-African9 S. Typhimurium genomes
were included in the overall analysis. The complete list of 276
analysed S. Typhimurium genomes with the year, place and
source of isolation is presented in Supplementary Data 2.
This analysis revealed a sublineage II.1 in DRC deﬁned by the
most recent common ancestor of the monophyletic sublineage of
51 XDR isolates (Fig. 2a). One isolate, 5390_4, originating from
Kisangani (2016) while being MDR, ESBL producing, AZI
resistant and showing DCS, falls outside sublineage II.1, but is
part of the clonal lineage II. All 27 control isolates also fall into
lineage II, with two older isolates from Kisantu (2009) being most
closely related to sublineage II.1 (1577 and 1582).
The S. Typhimurium ST313 lineage I and II in our study
accumulated 225 and 216 conserved single nucleotide
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Fig. 1 Geographical origin of S. Typhimurium showing azithromycin resistance in the Democratic Republic of the Congo (DRC). Red dots with numbers (n)
of the included resistant strains in the respective surveillance sites (Kinshasa, Kisangani and Kisantu). The map of DRC was constructed using the maps
package in R80
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polymorphisms (SNPs) respectively in their core genomes
compared to their most recent common ancestor (Supplementary
Fig. 1), which is comparable to previous observations17. In
comparison to the lineage II clade, all sublineage II.1 isolates,
except 2735, accumulated an additional 38 conserved core SNPs,
and show a clonal structure with little substructure (Fig. 2b). Of
note, the two isolates showing an AZI MIC value >256 mg L−1
form a monophyletic clade within sublineage II.1 (17399_3 and
17568_3). No SNPs were acquired in known genes involved in
macrolide resistance27, but both isolates have a G118V amino
acid substitution in the ABC-transporter protein BtuC. This SNP,
in addition to the presence of mphA, might be involved in the
observed increased AZI resistance28. Cephalosporin resistant
ST313 lineage II infections were previously reported from Kenya
and Malawi10–12. The XDR isolates we describe here form
ST313 sublineage II.1.
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The putative origin of the ST313 lineage II was previously
predicted to be the DRC9. Consequently, we applied a temporal
reconstruction using BEAST2 to the S. Typhimurium ST313
lineage II and II.1 isolates. This limited analysis indicates that
sublineage II.1 may have emerged in the DRC around 2004 (95%
highest probability density (HPD) interval: 2000–2007) (Fig. 3).
Lineage II.1 harbours an IncHI2 resistance plasmid, pSTm-
ST313-II.1. A comprehensive resistome, composed of all cata-
logued genetic determinants for antimicrobial resistance (AMR),
was bioinformatically extracted from the sequencing data (Sup-
plementary Data 2). This analysis indicates that the MDR phe-
notype observed in S. Typhimurium ST313 lineage II and
sublineage II.1 isolates is associated with genes predicted to confer
resistance to chloramphenicol (catA), ampicillin (blaTEM1) and
trimethoprim (dfrA). While lineage II is linked to the presence of
dfrA1, this allele is replaced by dfrA14 in sublineage II.1. XDR
sublineage II.1 isolates harbour blaSHV-2A and mphA genes,
respectively potentially associated with resistance to cephalos-
porins and azithromycin, respectively. Identical blaSHV-2A and
mphA genes are present in the ESBL positive, AZI resistant
lineage II isolate from Kisangani (5390_4). One sublineage II.1
isolate, 2735, showed DCS (MIC value ciproﬂoxacin= 0.19 g L−1)
in addition to AZI resistance and ESBL production and harbours
a mutation in gyrA (D87N) associated with DCS. DCS combined
with ESBL positivity and AZI resistance was also observed in the
lineage II isolate 5390_4 (Kisangani, 2016, MIC value cipro-
ﬂoxacin= 0.38 g L−1), which has acquired a qnrS gene. The
lineage II isolate 16755_3 (Kisantu, 2016, MIC value cipro-
ﬂoxacin= 0.19 g L−1) showed DCS but no ESBL activity nor AZI
resistance and harbours a S83Y mutation in gyrA.
All sublineage II.1 isolates as well as the lineage II 5390_4
isolate (ESBL+AZI) from Kisangani harbour an IncHI2 plasmid.
IncHI2 plasmids have been reported previously in other S.
Typhimurium ST313 isolates from Kenya (pKST313) and Malawi
(pSTm-A54650)10,11. We have named the ST313 sublineage II.1
IncHI2 plasmid pSTm-ST313-II.1. The full pSTm-ST313-II.1
plasmid sequence associated with sublineage II.1 was determined
using PacBio sequencing of isolate 10433_3 (Kisantu, 2014).
pSTm-ST313-II.1 is 274,695 nucleotides (Fig. 4) and is highly
conserved among all sublineage II.1 isolates, differing by ~5 single
SNPs between isolates. The known AMR determinants of
ST313 sublineage II.1 are located on pSTm-ST313-II.1, alongside
genes associated with heavy metal resistance against silver and
copper. pSTm-ST313-II.1 encodes a potentially active TraB
conjugation protein and conjugation operon29.
pSTm-ST313-II.1 exhibits signiﬁcant similarity to R478 (99%
identity over 86% coverage of pSTm-ST313-II.1), a self-
transferable IncHI2 plasmid isolated from Serratia marcescens
in 1969 in the USA30. Pairwise sequence comparisons of pSTm-
ST313-II.1 with the other IncHI2 plasmids (1) pKST313 from
Kenya, (2) pSTm-A54650 from Malawi, a (3) draft assembly from
the IncHI2 plasmid of 5390_4 from Kisangani, and R478 revealed
the signiﬁcant similarity between the plasmid backbones (Fig. 4
and Supplementary Table 1). The less conserved regions of
pSTm-ST313-II.1 include AMR genes, ﬂanked by transposon-
associated regions (Fig. 4).
Sublineage II.1 exhibits signatures of host adaptation.
ST313 sublineage II.1 harbours multiple chromosomal sequence
differences in comparison to ST313 lineage II isolates (Fig. 5). A
deletion of 1076 nt was observed in the chromosome of
ST313 sublineage II.1, resulting in loss of ﬂjB. The ﬂjB gene codes
for the phase 2 ﬂagellin protein which polymerizes to form the
bacterial ﬂagella (Supplementary Fig. 2). Loss of ﬂjB (FljB) was
conﬁrmed at the DNA and protein levels (Supplementary Fig. 3).
Consequently, in contrast to their biphasic ancestors, sublineage
II.1 isolates are monophasic as they only harbour the phase 1
ﬂagellin gene, ﬂiC.
We annotated the SNPs that were acquired in ST313 sublineage
II.1 relative to lineage II (Supplementary Tables 2–4). Of these
SNPs, 19 are present in coding regions and cause predicted non-
synonymous mutations in the protein sequence (Supplementary
Tables 2–4). Seven of these 19 SNPs are located in conserved
Pfam protein domains resulting in deviant bitscores. Conse-
quently, we prioritized these SNPs as the most likely to cause
functional defects. The affected genes are geranyltranstransferase
ispA, methyl-accepting chemotaxis protein trg_1, precorrin-3B
C17-methyltransferase cbiH, propanediol dehydratase reactiva-
tion protein, outer membrane assembly protein asmA, putative
multidrug export ATP-binding/permease protein SAV1866 and
putative diguanylate cyclase yhjK. These genes have been linked
to host-adaptation (cbiH)16, virulence-associated processes
(asmA)31, and chemotaxis during infection (trg_1)32. Of note,
these molecular processes are also linked to pseudogene
accumulation in the phylogeny from S. Typhimurium ST19 to
ST313 lineage II17.
As our interpretations are likely biased by the available
literature, we applied a data mining approach to obtain a more
objective evaluation of the association between the acquired
SNPs in sublineage II.1 and invasiveness. Hereto, the Salmo-
nella invasiveness index of each strain was calculated, which is
based on the genomic signatures for S. enterica associated with
adaptation to an invasive lifestyle33. We observe an increase in
invasiveness index from non-ST313 and ST313 lineage I isolates
to lineage II, and a signiﬁcant further increase of the
invasiveness index from lineage II to lineage II.1 (Fig. 6a,
Supplementary Fig. 3).
Fig. 2 The population structure of S. Typhimurium ST313 with emergence of sublineage II.1. a Maximum likelihood phylogenetic tree based on the 81
genome sequences from this study and 153 African and 42 non-African publicly available S. Typhimurium strains (summarized in Supplementary Data 2).
Sequencing reads were mapped to S. Typhimurium ST313 lineage II reference strain D2358056. The tree is based on 62,884 chromosomal SNPs. Branches
of S. Typhimurium ST313 sublineage II.1 are coloured in red. Metadata is visualized on the concentric rings in compliance to the legend, from the inside to
outside; 1. Country of origin, 2. Year of isolation, 3. Presence of IncHI2 replicon, 4–8. Presence of multidrug resistance markers (MDR; bla, cat, sul, dfrA),
mphA, blaSHV-2A, qnrS and gyrA antimicrobial resistance markers (AMR). Reference strains A130 (lineage I), D23580 (lineage II) and 10433_3 (sublineage
II.1), as well as strain 5390_4, are indicated in blue. Branch lengths represent the number of SNPs as indicated in the scale bar. The tree is publicly available
on MicroReact (https://microreact.org/project/xS5Xw6b3A). b Maximum likelihood phylogenetic tree of all S. Typhimurium ST313 lineage II strains
included in this study, based on mapping to sublineage II.1 reference strain 10433_3 (this study). The tree is based on 1207 chromosomal SNPs. A
collapsed branch is annotated with a grey triangle. The tree is rooted with S. Typhimurium strain DT2B, a European ST313 strain. Branches of S.
Typhimurium ST313 sublineage II.1 are coloured in red. Metadata is visualized in lanes in compliance to the legend, from left to right; 1. Country of origin, 2.
Year of isolation, 3. Presence of IncHI2 replicon, 4–8. Presence of multidrug resistance markers (MDR; bla, cat, sul, dfrA), mphA, blaSHV-2A, qnrS and gyrA
AMR markers, 9. Location in the Democratic Republic of the Congo (DRC). Reference strain 10433_3 (sublineage II.1) is indicated in blue. Branch lengths
are indicated and represent the number of SNPs. The map of DRC was constructed using the maps package in R80
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In addition to the observed genomic differences, S.
Typhimurium ST313 sublineage II.1 isolates exhibited measur-
ably different phenotypes compared to S. Typhimurium ST313
lineage II. A red dry and rough (rdar) bioﬁlm assay was
performed that uses agar plates with stains that reveal
extracellular matrix production in colonies. In this assay, S.
Typhimurium ST313 lineage II isolates lost the rough
morphotype compared to ST19, changing from a rdar to a
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Fig. 3 Bayesian time-tree of S. Typhimurium ST313 lineage II Bayesian maximum clade credibility phylogeny of African S. Typhimurium ST313 lineage II and
sublineage II.1 isolates. The time-tree is based on 1187 SNP differences detected across the core genome of 175 lineage II and II.1 sequenced isolates. The
tree was visualized and coloured in Figtree v1.4.2, with the horizontal axis representing the years. A divergence date (median estimate and its respective
95% HPD) is indicated for the ST313 II.1 sublineage. Tree tips are colour coded according to their country of origin (coloured by legend at top)
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brown and smooth (bas) phenotype. This phenotype was shown
previously to be due to defective production of cellulose, one of
the two major extracellular components of Salmonella
bioﬁlms18,20. Interestingly, S. Typhimurium ST313 lineage
II.1 show a further defect in bioﬁlm formation. Sublineage
II.1 isolates have a smooth and white (saw) colony morphotype
in this assay, whereas sublineage II isolates have a brown and
smooth (bas) morphotype (Fig. 6b). This phenotypic defect is
consistent across all isolates from sublineage II.1 and resembles
the S. Typhi morphotype. The exception was isolate 2735
(Kinshasa, 2008), the phylogenetically oldest representative of
sublineage II.1 (Supplementary Fig. 4)19. Among the SNPs that
were acquired in sublineage II.1 compared to lineage II, none
were located in or near genes responsible for the production of
curli, which is another major bioﬁlm compound. Mutagenesis
experiments showed that the introduction of a null mutation
into the asmA gene of S. Typhimurium ST313 lineage II
D23580 partly recreated the sublineage II.1 bioﬁlm phenotype
(Fig. 6b), suggesting that the non-synonymous SNP in asmA
might contribute to the bioﬁlm defect. asmA encodes an outer
membrane protein that was previously described to be involved
in the invasion of epithelial cells31. Targeted mutations in
wzxC, yhjJ and yhjK in D23580 had no obvious effect on the
bioﬁlm phenotype (Supplementary Fig. 5).
While Salmonella causing gastrointestinal infections typically
have a relatively large metabolic capacity, strains causing
invasive infections generally have a more limited capacity34. We
used Biolog Phenotype Microarrays to assess growth on 192
different metabolic compounds between two representative
isolates of both lineage II and lineage II.1. Lineage II.1 isolates
showed signiﬁcant lower metabolic capacity for carbon com-
pounds compared to lineage II isolates (Supplementary Data 3).
The effect was most pronounced for D-galactonic acid γ-lacton
(Supplementary Fig. 6).
We also assessed the phenotypic behaviour of ﬁve representa-
tive sublineage II.1 isolates in in vitro and in vivo models. Human
macrophage infections and intravenous and oral mouse infections
did not show signiﬁcant differences between the lineages,
although two sublineage II.1 isolates showed an overall lower
infection of THP macrophages and cell counts in mouse deep
tissue after intravenous infections (Supplementary Figs. 7–9).
Discussion
Here, we report the emergence of S. Typhimurium ST313 sub-
lineage II.1 from the DRC showing XDR. The World Health
Organization (WHO) has listed Salmonella spp. as one of the
pathogens for which new antibiotics are urgently needed35. In
addition to the MDR phenotype of lineage II9, sublineage II.1 is
associated with ESBL activity, AZI resistance and occasional DCS,
thereby giving rise to the ﬁrst lineage of XDR iNTS. As there is no
XDR deﬁnition for iNTS yet, we extrapolate the deﬁnition from
XDR S. Typhi, recently deﬁned as resistant to ﬁve antibiotics
(observed as MDR combined with resistance against ﬂuor-
oquinolones and ESBL activity), thereby using the same
nomenclature as for other bacterial pathogens36,37. The XDR
iNTS isolates from this study show MDR in combination with
resistance to the two alternative treatment options ceftriaxone
and AZI.
Sublineage II.1 was identiﬁed in three independent surveillance
sites in the DRC, suggesting this sublineage is relatively wide-
spread in the region, although further surveillance is required to
conﬁrm the burden14,38–40.
All except three of the S. Typhimurium ST313 lineage II.1
isolates described here fall into the XDR category deﬁned for S.
Typhi36,37. Within the DRC setting, the only available antibiotics
for treatment of XDR iNTS infections are ﬂuoroquinolones.
Importantly, DCS iNTS is present in DRC, with one pan-resistant
(XDR+DCS) isolate identiﬁed in this study. The emergence of
this XDR iNTS sublineage II.1 increases the urgency for
advancements in other strategies, such as vaccination, to combat
the disease.
Antibiotic use might have provided the selection pressure
driving the emergence of this sublineage. Within SSA, the anti-
biotic AZI has been used in mass drug administrations for the
elimination of Trachoma, and has also recently been tested to
reduce childhood mortality41. In the DRC, it is not clear which
antibiotics are in routine use, as only 30% of patients have access
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Fig. 5 Genomic changes in S. Typhimurium ST313 sublineage II.1 versus ST313 lineage II. A schematic overview of the genomic differences between S.
Typhimurium ST313 sublineage II.1 versus ST313 lineage II is shown. The genetic changes in S. Typhimurium sublineage II.1 include the acquisition of a
resistance plasmid, pSTm-ST313-II.1, the loss of the ﬂagellin ﬂjB gene and the acquisition of single nucleotide polymorphisms (SNPs) in the chromosome
sequence
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to the regular healthcare system, and 40% rely on self-
medication42. MDR in ST313 sublineage II.1 is linked here with
the IncHI2 plasmid pSTm-ST313-II.1. Intriguingly, previous
reports have associated iNTS S. Typhimurium in SSA with
IncHI2 plasmids10,11,43.
The acquisition of antibiotic resistance and the accumulation
of genomic signatures associated with host adaptation by sub-
lineage II.1 suggest further specialization to a human niche16,17.
Sublineage II.1 are monophasic, a phenotype similar to
typhoidal Salmonella44. A large recombination event took place
at the ﬂjB locus, resulting in loss of phase II ﬂagellin produc-
tion, while the phase I ﬂagellin gene ﬂiC remained intact.
Bacterial ﬂagellin plays an important role in the host innate
immune response and is a stimulator of innate immunity
through Tlr545,46. Strikingly, a pandemic of monophasic S.
Typhimurium ST34 causing gastrointestinal infections has
recently been identiﬁed, with some strains of this pandemic
causing bloodstream infections in Vietnam47,48. Sublineage II.1
have a reduced capacity to form multicellular communities
compared to lineage II18, again with similarity to S. Typhi19.
Bacterial bioﬁlms are important for both resistance to envir-
onmental stresses and survival outside the host. S. Typhimur-
ium ST313 sublineage II.1 isolates also show a lower capacity
for the metabolism of carbon sources, in line with the ﬁndings
that S. Typhimurium ST313 has a reduced metabolic capacity
compared to S. Typhimurium ST1917.
Survival in macrophages was experimentally assessed, given the
observed mutations in sublineage II.1, such as loss of ﬂjB, which
can affect macrophage survival20. However, we did not ﬁnd sig-
niﬁcant differences between lineage II and sublineage II.1 in
macrophage infection assays. Likewise, II.1 isolates did not show
a reproducible increased colonization of deeper tissue during
intravenous or oral mouse infections. Although our genomic,
bioﬁlm and metabolic data show signatures for increased human
adaption of lineage II, S. Typhimurium ST313 lineage II.1 isolates
are thus far not host restricted.
In conclusion, in this study we identiﬁed an on-going outbreak
of sublineage II.1 emerging from the current African S. Typhi-
murium ST313 pandemic. Sublineage II.1 is associated with XDR
driven by an IncHI2 plasmid named pSTm-ST313-II.1, har-
bouring resistance to AZI and ESBL production. In addition,
sublineage II.1 also shows evolutionary signatures associated with
host adaptation. Extended bloodstream surveillance in the
endemic regions of S. Typhimurium ST313 will be crucial to
further track the spread of XDR ST313 sublineage II.1 and to
timely detect the emergence of sublineages with novel antibiotic
resistance proﬁles.
Methods
Isolate selection from bloodstream surveillance. The DRC isolates originated
from blood cultures sampled at the referral hospital of Saint Luc in Kisantu (Kongo
Central province), the University Hospital of Kinshasa, the referral Hospital St.
Joseph and Monkole Hospital from Kinshasa (Kinshasa province), the referral
hospital of Bwamanda (Tshopo province), the referral hospital of Kabondo and the
university hospital of Kisangani (CUKIS) and associated health centres (Sud-
Ubangi province) in the DRC14,24,40. These hospitals have participated in the
microbiological surveillance network since 2007 coordinated by the National
Institute of Biomedical Research (INRB) in Kinshasa, DRC, in collaboration with
the Institute of Tropical Medicine (ITM) in Antwerp, Belgium. Blood cultures were
sampled in patients suspected of bloodstream infections according to standard
indications and methods as described elsewhere14.
All available AZI resistant S. Typhimurium available to this study were included
(n= 54). A sample of 27 representative non-AZI resistant S. Typhimurium isolates
were selected as controls for this analysis. Most health facilities across the country
lack capacity for diagnosing bacterial bloodstream infections and we have therefore
no information about bloodstream infections elsewhere in DRC except as part of
outbreak research38,39. The surveillance sites included in this study were not
consistently active because of stock ruptures, staff movements, funding and
insecurity. All isolates were stored in tubes of Trypticase Soya Agar (Oxoid,
Basingstoke, UK) and shipped to ITM for conﬁrmation and further identiﬁcation.
At ITM, isolates biochemically conﬁrmed as Salmonella spp. were serotyped
using commercial antisera (Siﬁn, Berlin, Germany) according to the Kauffmann-
White scheme49. A representative selection of the isolates (10%) was sent to the
National Reference Centre in Belgium for conﬁrmation of serotype. Antibiotic
susceptibility testing of all isolates was done by disk diffusion (Neo Sensitabs,
Rosco, Taastrup, Denmark) according to the National Committee for Clinical
Laboratory Standards (CLSI) guidelines; for ciproﬂoxacin and AZI, minimal
inhibitory concentration (MIC-values) were determined with the E-test
macromethod (bioMérieux). Interpretation of results was performed according to
the most recent CLSI guideline50. Isolates with intermediate susceptibility were
considered resistant. MDR was deﬁned as co-resistance to all three ﬁrst-line
antibiotics ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole15.
ESBL production was assessed by double disk method according to CLSI
guidelines50. For ciproﬂoxacin, the susceptibility breakpoint of ≤0.064 mg L−1 was
used; the term decreased ciproﬂoxacin susceptibility was used to indicate MIC
values >0.064 mg L−1 and <1 mg L−1, and ciproﬂoxacin resistance was reserved for
MIC values ≥1 mg L−150. For AZI, isolates were considered resistant at MIC values
≥16 mg L−150. Ethical approval for the Microbiological Surveillance was granted by
the Institutional Review Board at the ITM in Antwerp, by the Ethics Committees of
the Antwerp University (Belgium) and the School of Public Health
(Kinshasa, DRC).
Illumina and Pacbio whole-genome sequencing. DNA from all 81 strains was
puriﬁed using the Gentra PureGene Yeast/Bact Kit (Qiagen, Hilden, Germany),
following the manufacturer’s guidelines and DNA was sequenced on an Illumina
HiSeq platform (Illumina, San Diego, USA). Illumina adapter content was removed
from the reads using Trimmomatic v.0.3351. Public available Illumina sequencing
data from 153S. Typhimurium strains originating from DRC, Mali, Nigeria,
Uganda, Kenya, Malawi and Mozambique and a selection of 42 non-African
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Fig. 6 Signatures for host adaptation of S. Typhimurium ST313 Sublineage
II.1. a Invasiveness index values for all S. Typhimurium sequences included
in this study, grouped into lineage, as calculated by the method of Wheeler
et al.33. Summary of statistics on different clades: Non-ST313: median=
0.184, standard deviation (SD)= 0.093; Lineage I: median= 0.185, SD=
0.003; Lineage II: median= 0.205, SD= 0.005; Lineage II.1: median=
0.222, SD= 0.004. The groups were compared using a Mann Whitney U-
test. Boxplot centre lines represent median values; box limits represent
upper and lower quartiles; whiskers represent the 1.5 interquartile range
and points represent the outliers. Source data are provided as a Source
Data ﬁle. b Red, dry and rough (rdar) morphotype75 of S. Typhimurium
ST313 lineage II strain D2358056, S. Typhimurium ST313 lineage II.1 strain
10433_3 (this study) and a S. Typhimurium ST313 lineage II D23580 asmA
knock-out strain (this study). Source data are provided as a Source Data ﬁle
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genomes were included in the further genomics analysis9–12,26. This is a con-
venience sample including all publicly available African iNTS genomes. Strains are
summarized in Supplementary Data 2.
A high-quality reference genome sequence of sublineage II.1 isolate 10433_3
was constructed using the PacBio RS II platform (PacBio, Menlo Park, CA, USA).
The PacBio Template Prep Kit (PacBio, Menlo Park, CA, USA) and BluePippin™
Size Selection System protocol were used to prepare size-selected libraries (20 kb)
from 5 μg of sheared and concentrated DNA. Sequencing was performed using the
magnetic bead collection protocol, a 20,000 bp insert size, stage start, and 180-min
movies. Sequence reads were assembled using HGAP v3 28 of the SMRT analysis
software v2.3.0 (Pacbio, Menlo Park, CA, USA). The fold coverage to target when
picking the minimum fragment length for assembly was set to 30 and the
approximate genome size was set to 3Mbp. The assembly was circularized using
Circlator v1.1.352. Finally, the circularized assembly was polished using the PacBio
RS_Resequencing protocol and Quiver v1 of the SMRT analysis software v2.3.053.
Automated annotation was performed using PROKKA v1.1154 and genus speciﬁc
databases from RefSeq55. The ﬁnal assembled bacterial chromosome consisted of
4,877,289 bp, and two plasmid sequences of 274,695 bp and 94,649 bp.
Read mapping, variant detection, and phylogenetic analysis. Illumina HiSeq
reads were mapped to the S. Typhimurium reference genomes of ST313 lineage II
(D23580, FN424405.156) and ST313 sublineage II.1 (10433_3, ERZ1030005, this
study) using SMALT v0.7.4 to produce a BAM ﬁle.
SMALT was used to index the reference using a kmer size of 20 and a step size
of 13 and the reads were aligned using default parameters but with the maximum
insert size set as 3 times the mean fragment size of the sequencing library. PCR
duplicate reads were identiﬁed using Picard v1.92 (Broad Institute, Cambridge,
MA, USA) and ﬂagged as duplicates in the BAM ﬁle.
Variation detection was done using samtools mpileup v0.1.19 with parameters
-d 1000 -DSugBf and bcftools v0.1.1957 to produce a BCF ﬁle of all variant sites,
using the option to call genotypes at variant sites. The bcftools variant quality score
was set to be greater than 50 (quality < 50), mapping quality was set to be greater
than 30 (map_quality < 30), the allele frequency was required to be either 0 for
bases called the same as the reference, or 1 for bases called as a SNP (af1 < 0.95), the
majority base call was set to be present in minimal 75% of the reads mapping at the
base (ratio < 0.75), the minimum mapping depth was four reads (depth < 4), at least
two of these four had to map to each strand (depth_strand < 2), strand_bias was set
to be less than 0.001, map_bias less than 0.001 and tail_bias less than 0.001.
Otherwise, the base was called as uncertain and removed.
A pseudo-genome was constructed by substituting the base calls in the BCF ﬁle
in the reference genome, uncertain sites were substituted with Ns. Insertions with
respect to the reference genome were ignored, deletions were ﬁlled with N’s in the
pseudo-genome.
Recombinant regions in the chromosome such as prophage regions and the ﬂjB
ORF in the chromosome were removed from the alignment and checked using
Gubbins v1.4.1058. SNP sites were extracted from the alignment using snp-sites59 and
used to construct a maximum likelihood phylogeny. RAxML v8.2.860 with substitution
model GTRCAT. Support for nodes on the trees was assessed using 1000 bootstrap
replicates. A comprehensive tree, with reads mapped to ST313 lineage II (D23580,
FN424405.156) was rooted on S. Paratyphi A270 (ERR326600). Based on this tree,
lineage II and sublineage II.1 isolates were identiﬁed and a high-resolution lineage II
tree was constructed based on mapping to ST313 sublineage II.1 (10433_3, this study)
and rooted to S. Typhimurium ST313 strain DT2. Trees were visualized using Figtree
v1.4.2 and iTOL61. The comprehensive phylogenetic tree with spatiotemporal
metadata, based on mapping against D23580 and rooted on S. Paratyphi A270 is made
publicly available on MicroReact62 (https://microreact.org/project/xS5Xw6b3A).
Bayesian phylogenetic analysis. We used BEAST2 v2.4.863 to date evolutionary
events, determine the substitution rate and produce a time-tree of African S.
Typhimurium with tip-dates deﬁned as the year of isolation (Supplementary Data
2). BEAUti xml’s were manually modiﬁed to specify the number of invariant sites
in the genome. We employed a general time reversible (GTR) substitution model
with gamma distributed rate heterogeneity. In addition, an uncorrelated log-
normal relaxed molecular clock64 was used to model the variation of evolutionary
(substitution) rates across branches. The extended Bayesian skyline plot (EBSP)
demographic method65 was selected as this model does not depend on a pre-
speciﬁed parametric model of demographic history and the method has been
proven to indicate the most appropriate demographic model for any given dataset.
Earlier BEAST analyses on a related dataset identiﬁed the molecular clock model
and tree prior used here to have the highest support by using Bayes factor (ratio of
the marginal likelihoods of two competing models) based model selection9.
All parameters were estimated jointly in a BEAST2 analysis using 10
independent chains of 500 million MCMC generations, with samples taken every
50,000 generations. Log ﬁles were inspected in Tracer v1.6 for convergence, proper
mixing, and sufﬁcient sampling, assessed by whether the chain length produced an
effective sample size (ESS) for all parameters larger than 300. A 30% burn-in was
removed from each run, and LogCombiner v2.5.0 was used to combine log and tree
ﬁles of the independent BEAST2 runs. Parameter medians and 95% highest
posterior density (HPD) intervals were ﬁnally estimated from 70,000 sampled
MCMC generations. The entire analysis was replicated on ﬁve random subsets of
100 taxa of the dataset to test if the results were affected by sampling bias.
The entire analysis was run while sampling only from the prior, to ensure that
prior parameters were not causing over-constraining of the calculations. The
resulting parameter distributions were compared in Tracer. The posterior sample
of the time-trees were summarized in TreeAnnotator v2.5.2 to produce a
maximum clade credibility tree with the posterior estimates of node heights
visualized on it.
Genomic rearrangements and SNP analysis. Large genomic rearrangements
were identiﬁed by analysis of the aligned reference genome sequences using the
Artemis Comparison Tool (ACT).
A VCF ﬁle containing all SNP sites was extracted using snp-sites59 from all
strains included in this study. Conserved SNPs between lineage II and lineage II.1
isolates were extracted using custom calculations in R v.3.3.3, thereby comparing
SNPs with the D23580 reference sequence and annotation (FN424405.1). SNPs
that were conserved in 51 of the 53 sublineage II.1 strains, and not present in
lineage II strains were subjected to a functional analysis. These SNPs were
functionally studied by comparison with the D23580 annotation56. Ortholog loci in
S. Typhimurium LT2 (NC_003197.2) were identiﬁed using BLASTN 2.6.0+.
For SNPs present in coding regions, the effect of the SNP on the respective
amino acid sequence was assessed. For non-synonymous SNPs, the PAM1 value
and delta bitscore value was included. The higher the PAM1 value, the more
frequent speciﬁc amino acid substitutions are observed. Delta bitscores were
calculated by subtracting the bitscore for a given HMM domain in lineage II from
the bitscore of the orthologous domain lineage II.1 strains66.
To calculate the invasiveness index per strain, sequence reads of each sample
were mapped against the S. Typhimurium SL1344 reference genome (FQ312003.1)
using BWA mem v0.7.1267 to produce a BAM ﬁle thereby using default parameters
but maximum insert size changed to 3 times the mean fragment size of the
sequencing library. We used Picard (http://broadinstitute.github.io/picard) to
identify optical duplicates generated during library preparation. SNPs were called
using samtools v1.2 mpileup68, variants with coverage < 10 or quality < 30 were
ﬁltered and excluded. SNP calls were used to produce variant coding sequences.
Protein sequences were then screened using phmmer to identify the closest
homologs to the 196 predictive genes used by the invasiveness index model. These
genes were then scored against proﬁle hidden Markov models (HMMs) for these
protein families from the eggNOG database to test for uncharacteristic patterns of
sequence variation. Bitscores produced in the comparison of each protein sequence
to its respective protein family HMM were then used as input to the model. The
groups were compared using a Mann Whitney U-test.
Sequence typing, resistance, and plasmid analysis. Resistance genes were
determined from the raw Illumina sequencing data using ariba v 2.11.169 with
CARD database version 1.1.870. SNPs explaining a DCS phenotype was checked
individually for strains showing DCS. The gyrA, gyrB, parC, parE, acrB sequences
of reference sequence from S. Typhimurium LT2 (NC_003197.2) were compared to
assemblies of the DCS strains using BLASTN 2.6.0+. The presence of plasmid
replicons was determined from raw Illumina reads using SRST271 with the com-
plementary P18 plasmid replicon database.
The PacBio reference sequence of plasmid pSTm-ST313-II.1 (S. Typhimurium
DRC, this study) was searched for similar nucleotide sequences publicly available
using NCBI Blast with the Nucleotide collection (nt), update 2017/07/13. Pairwise
comparisons were done using BRIG72. pSTm-ST313-II.1 was compared with
plasmids R478 (Serratia marcescens USA, BX664015), pKST313 (S. Typhimurium,
LN794248) and pSTm-A54650 (S. Typhimurium, LK056646). A de novo assembly
was performed based on Illumina sequences of isolate 5390_4 (This study)73 and
the assembly of the plasmid sequence was used for pairwise comparative analysis.
Hereto, the contigs of the assembly were reordered using Mauve version
2015_02_2574 and the 12 contigs homologous to pSTm-ST313-II.1 were retained
for further analysis.
Flagella expression. Presence of ﬂjB (FljB) and ﬂiC (FliC) were conﬁrmed at the
DNA and protein level for a S. Typhimurium reference lineage II (isolate 9412_3)
and sublineage II.1 (10433_3) strain. DNA was extracted from both strains using
Gentra Puregene Yeast/Bact. Kit (Qiagen, USA) and PCR-ampliﬁed using ﬂjB (ﬂjB-
F and ﬂjB-R) and ﬂiC (ﬂiC-F and ﬂiC-R) speciﬁc primers (Supplementary Table 5).
For protein samples, overnight cultures were centrifuged at 1500 g and pellets
were suspended in 300 µL phosphate-buffered saline (PBS, pH 7.4). The suspension
was homogenized using FastPrep-24 (MP Biomedicals, Santa Ana, California,
USA) and centrifuged at 15,000 rpm. 10 µL of the supernatant was diluted 1:1 with
sample buffer (Laemmle, Sigma-Aldrich, St. Louis, Missouri, US) before loading on
SDS-page gel (12%). After running (45 min 100 V) the gel was coloured with
Coomassie blue.
Bioﬁlm assays. Strains were grown in 10 ml low salt LB Broth overnight, diluted
1:100 in PBS and 5 µL was spotted onto rdar phenotype plates (1.5% Agar, 1%
Tryptone, 0.5% Yeast Extract, 20 µg mL−1 Coomassie Brilliant Blue, 40 µg mL−1
Congo Red in water)75. The plates were incubated at 27 °C without inversion for
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84 h, phenotype analysed and photographed. Colonies were quantitatively analysed
using the IRIS software76.
Biolog assays. Four S. Typhimurium ST313 lineage II (12299_3, 9266_3, 9412_3
and D23580) and four S. Typhimurium sublineage ST313 sublineage II.1 (10393_3,
10433_3,12306_3 and 8866_3) isolates were analysed on the OmniLog phenotype
MicroArray (PM) platform, in three independent biological replicates each.
Overnight cultures cells were transferred with a sterile swab to 15 mL IF-0 (12.5 mL
IF-0 with 2.5 mL H2O) and stirred to obtain a uniform suspension. Turbidity of the
suspension was adjusted to 42% transmittance T by using the Biolog Turbidimeter.
Plates PM 1 and PM 2 were inoculated with 100 µL per well of the cell suspension
mix diluted 1:5 in IF-0 containing 1.2% dye mix A. All plates were covered by
anaerobic sealing foil (Roche) and incubated in the Omnilog phenotype Micro-
Array system for 48 h at 37 °C. Statistical calculations and visualization were done
in R (R Core Team) by using the opm package77. The curve parameters were
estimated using spline ﬁtting. The mean of the area under the curve (AUC) was
compared between sublineage II.1 versus lineage II strains using a linear model
based on a Tukey-type contrast using the opm_mcp function from the multcomp
package78.
Mutant construction. Mutant strains S. Typhimurium D23580 ΔasmA, S.
Typhimurium D23580 ΔyhjJ, S. Typhimurium D23580 ΔyhjK and S. Typhimurium
D23580 ΔwxzC were constructed. Hereto, the Kanamycin resistance gene (kan)
was PCR-ampliﬁed from pKD4 using Q5 HotStart DNA Polymerase (New England
Biolabs, Massachusetts, U.S.A.) and gene speciﬁc oligos (Integrated DNA Tech-
nologies, Illinois, USA) for asmA (asmA-F and asmA-R), wzxC (wzxC-F and
wzxC-R), yhjJ (yhjJ-F and yhjJ-R) and yhjK (yhjK-F and yhjK-R), listed in Sup-
plementary Table 5. DNA was prepared by gel extraction (Qiagen, Hilden, Ger-
many) and ethanol precipitation.
The pSIM18 vector carrying the lambda RED recombinase system79 was
electroporated into S. Typhimurium D23580 using 10.5 ng DNA at a setting of 2.5
kV, 200 ohms and 25 µF (Bio-Rad MicroPulser, California, USA). 750 µL of SOC
outgrowth medium (Thermo Fisher Scientiﬁc, Massachusetts, USA) was added and
cells grown at 30 °C for 90 min, 100 μL aliquots were plated out onto plates
containing Hygromycin and colonies recovered next day. The subsequent S.
Typhimurium D23580::pSIM18 was used to create the mutant strains.
S. Typhimurium D23580::pSIM18 was grown overnight at 30 °C and then diluted
1 in 100 the next day in low salt LB plus 100 µgmL−1 Hygromycin B (Thermo Fisher,
Massachusetts, U.S.A.) and incubated for 3 h, shaking at 30 °C to an optical density
(OD) of 0.4. The culture was heat-shocked at 42 °C for 15min, cooled on ice for 10
min and then was spun for 10min at 2500×g and washed twice in ice cold 10%
glycerol. The cell pellet was ﬁnally resuspended in 140 µL of 10% glycerol and 60 µL
aliquots were electroporated with 1 µg of DNA (Table 1) in a precooled 2mm
electroporation cuvette. Cells were then incubated in 500 µL of pre-warmed SOC
outgrowth medium (Thermo Fisher Scientiﬁc, Massachusetts, USA) at 37 °C for 2 h.
3 × 100 µL aliquots were plated onto 50 µgmL−1 Kanamycin (Thermo Fisher,
Massachusetts, USA) LB plates and grown overnight at 37 °C. The remaining volume
was left at room temperature overnight and plated on 50 µgmL−1 Kanamycin and
left to grow at 37 °C. The knock-out mutation was conﬁrmed using Illumina
sequencing.
THP-1 macrophage invasion and replication assay. THP-1 monocytes (Eur-
opean Collection of Authenticated Cell Cultures (ECACC), cat no. 88081201)
were plated at 1 × 105 cells per well in RPMI (Gibco) with 2 mM L-glutamine
(Sigma) and 10% foetal bovine serum (Sigma) with PMA (Phorbol 12-myristate
13-acetate, (Sigma) to differentiate to macrophages. After 72 h, media was chan-
ged to the supplemented RPMI (as deﬁned above) for 24 h before infection.
Bacterial isolates SL1344, D23580, 2101, 9266_3, 12299_3, 6948_3, 9412_3,
10055_3, 8866_3, 12155_3, 10393_3, and 10433_3 were inoculated in 10 mL low-
salt lysogeny broth (LB) from frozen stocks and incubated at 37 °C, shaking for
~17.5 h prior to use. For infection, bacteria were diluted in PBS to an OD of 1
before adding to RPMI. 500 µL of bacteria in media were added to cells for a
multiplicity of infection of 20:1 and incubated at 37 °C for 30 min. At 30 min,
media containing bacteria was removed and replaced with media containing 0.1
mg mL−1 gentamicin. For the 1 h invasion timepoint, at 1 h post-infection, cells
were washed 1x in PBS then lysed in 1% Triton, and serial dilutions at 10−1, 10−2,
10−3 prepared in PBS. 50 µL of each dilution was spotted on LB agar plates in 5
technical replicates of 10 µL spots and incubated at 37 °C. For the 6 h intracellular
replication timepoint, gentamicin-containing media was replaced by the supple-
mented RPMI at 1 h post-infection and incubated at 37 °C for another 5 h. At 6 h
post-infection, cells were washed 1× in PBS and lysed with 1% Triton, as for the
cells at the 1 h timepoint. Agar plates were incubated until colony forming units
were visible for counting to calculate viable bacteria per mL. Experiments were
done in three biological replicates, mean and standard error of the mean was
calculated for all strains.
Mouse infection. Salmonella strains were grown static overnight in LB at 37 °C.
Inoculations were prepared by diluting overnight culture in PBS. Inoculums were
plated post infection on LB agar plates for conﬁrmation. Groups of C57/Bl6 mice
were pre-treated with 50 mg of Streptomycin by oral gavage and infected intra-
venously with 2 × 102 colony forming units (CFU) or orally with 2 × 106 CFU with
each Salmonella strain. At day 4 post infection mice were culled and organs
removed. Homogenised organs were serially diluted in PBS and 20 µL of each
dilution were spotted into LB agar plates. CFUs were counted next day to calculate
number of CFUs per organ. All experiments on animals were performed under a
UK animal license that has been through local ethical review before being approved
by Sanger—Animal Welfare and Ethical Review Body (AWERB) and performed
according to the regulations of the UK Home Ofﬁce Scientiﬁc Procedures Act
(1986).
Material availability. Requests for obtaining biological material (mutant strains)
should be addressed to the corresponding author. Exchange of clinical isolates
should always be in agreement with the ITM (Antwerp, Belgium) and INRB
(Kinshasa, DRC), co-owning the bacterial isolates.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
Sequence data that support the ﬁndings of this study have been deposited in SRA with
accession codes as listed in Supplementary Data 1. The annotated Pacbio’d reference
genome of Salmonella Typhimurium strain 10433_3 is uploaded to GenBank with
accession ID ERS1310131. The generated phylogenetic tree (as presented in Fig. 2a) is
publicly accessible in MicroReact: https://microreact.org/project/ZfwCFTj2-/d9f0ce6f.
The source data underlying Fig. 6a, b and Supplementary Figs 6, 9–11 are provided as
Source Data File. All other datasets generated during and/or analysed the current study
are available from the corresponding author on reasonable request.
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type II et des troubles mentaux. (2014).
43. Harrois, D. et al. Prevalence and characterization of extended-spectrum beta-
lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal,
from 1999 to 2009. Clin. Microbiol Infect. 20, O109–O116 (2014).
44. McClelland, M. et al. Comparison of genome degradation in Paratyphi A and
Typhi, human-restricted serovars of Salmonella enterica that cause typhoid.
Nat. Genet 36, 1268–1274 (2004).
45. McQuiston, J. R., Fields, P. I., Tauxe, R. V. & Logsdon, J. M. Jr. Do Salmonella
carry spare tyres? Trends Microbiol 16, 142–148 (2008).
46. Ikeda, J. S. et al. Flagellar phase variation of Salmonella enterica serovar
Typhimurium contributes to virulence in the murine typhoid infection model
but does not inﬂuence Salmonella-induced enteropathogenesis. Infect. Immun.
69, 3021–3030 (2001).
47. Petrovska, L. et al. Microevolution of Monophasic Salmonella Typhimurium
during Epidemic, United Kingdom, 2005–2010. Emerg. Infect. Dis. 22,
617–624 (2016).
48. Mather, A. E. et al. New variant of multidrug-resistant Salmonella enterica
Serovar Typhimurium associated with invasive disease in
immunocompromised patients in Vietnam. MBio 9, e01056–18 (2018).
49. Grimont P. A. D., Weill F.-X. Antigenic formulae of the Salmonellae serovars.
(World Health Organization, 2007).
50. CLSI. M100-S28: Performance Standards for Antimicrobial Susceptibility
Testing. (2018).
51. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a ﬂexible trimmer for
Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
52. Hunt, M. et al. Circlator: automated circularization of genome assemblies
using long sequencing reads. Genome Biol. 16, 294 (2015).
53. Chin, C. S. et al. Nonhybrid, ﬁnished microbial genome assemblies from long-
read SMRT sequencing data. Nat. Methods 10, 563–569 (2013).
54. Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30,
2068–2069 (2014).
55. Pruitt, K. D., Tatusova, T., Brown, G. R. & Maglott, D. R. NCBI Reference
Sequences (RefSeq): current status, new features and genome annotation
policy. Nucleic Acids Res. 40, D130–D135 (2012).
56. Kingsley, R. A. et al. Epidemic multiple drug resistant Salmonella
Typhimurium causing invasive disease in sub-Saharan Africa have a distinct
genotype. Genome Res 19, 2279–2287 (2009).
57. Li, H. et al. The sequence alignment/map format and SAMtools.
Bioinformatics 25, 2078–2079 (2009).
58. Croucher, N. J. et al. Rapid phylogenetic analysis of large samples of
recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids
Res. 43, e15 (2015).
59. Page, A. J. et al. SNP-sites: rapid efﬁcient extraction of SNPs from multi-
FASTA alignments. Micro. Genom. 2, e000056 (2016).
60. Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-
analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
61. Letunic, I. & Bork, P. Interactive tree of life (iTOL) v3: an online tool for the
display and annotation of phylogenetic and other trees. Nucleic Acids Res. 44,
W242–W245 (2016).
62. Argimon, S. et al. Microreact: visualizing and sharing data for genomic
epidemiology and phylogeography. Micro. Genom. 2, e000093 (2016).
63. Bouckaert, R. et al. BEAST 2: a software platform for Bayesian evolutionary
analysis. PLoS Comput Biol. 10, e1003537 (2014).
64. Drummond, A. J., Ho, S. Y., Phillips, M. J. & Rambaut, A. Relaxed
phylogenetics and dating with conﬁdence. PLoS Biol. 4, e88 (2006).
65. Heled, J. & Drummond, A. J. Bayesian inference of population size history
from multiple loci. BMC Evol. Biol. 8, 289 (2008).
66. Wheeler, N. E., Barquist, L., Kingsley, R. A. & Gardner, P. P. A proﬁle-based
method for identifying functional divergence of orthologous genes in bacterial
genomes. Bioinformatics 32, 3566–3574 (2016).
67. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
68. Li, H. A statistical framework for SNP calling, mutation discovery, association
mapping and population genetical parameter estimation from sequencing
data. Bioinformatics 27, 2987–2993 (2011).
69. Hunt, M. et al. ARIBA: rapid antimicrobial resistance genotyping directly
from sequencing reads. Micro. Genom. 3, e000131 (2017).
70. McArthur, A. G. et al. The comprehensive antibiotic resistance database.
Antimicrob. Agents Chemother. 57, 3348–3357 (2013).
71. Inouye, M. et al. SRST2: Rapid genomic surveillance for public health and
hospital microbiology labs. Genome Med 6, 90 (2014).
72. Alikhan, N. F., Petty, N. K., Ben Zakour, N. L. & Beatson, S. A. BLAST Ring
Image Generator (BRIG): simple prokaryote genome comparisons. BMC
Genom. 12, 402 (2011).
73. Page, A. J. et al. Robust high-throughput prokaryote de novo assembly and
improvement pipeline for Illumina data. Micro. Genom. 2, e000083 (2016).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11844-z ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4280 | https://doi.org/10.1038/s41467-019-11844-z | www.nature.com/naturecommunications 11
74. Darling, A. C., Mau, B., Blattner, F. R. & Perna, N. T. Mauve: multiple alignment
of conserved genomic sequence with rearrangements. Genome Res 14, 1394–1403
(2004).
75. Romling, U. Characterization of the rdar morphotype, a multicellular
behaviour in Enterobacteriaceae. Cell Mol. Life Sci. 62, 1234–1246 (2005).
76. Kritikos, G. et al. A tool named Iris for versatile high-throughput phenotyping
in microorganisms. Nat. Microbiol 2, 17014 (2017).
77. Vaas, L. A. et al. opm: an R package for analysing OmniLog(R) phenotype
microarray data. Bioinformatics 29, 1823–1824 (2013).
78. Hothorn, T., Bretz, F. & Westfall, P. Simultaneous inference in general
parametric models. Biom. J. 50, 346–363 (2008).
79. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes
in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97,
6640–6645 (2000).
80. Becker A. B. & Wilks A. R. Constructing a Geographical Database. AT&T Bell
Laboratories Statistics Research Report [952], (1995).
Acknowledgements
We are grateful to Ado Van Assche (K.U. Leuven, Leuven, Belgium), Eke van Zwol and
Janah Vandenhoeck (Institute of Tropical Medicine, ITM, Antwerp, Belgium) for
assistance with Biolog experiments; to Simon Harris, Jacqueline Keane, Nick Thomson
and the Pathogen Informatics team (Wellcome Sanger Institute, Hinxton, Cambridge,
United Kingdom) for the support and Bieke Tack for critical reading. This work was
funded by the Belgian Directorate of Development Cooperation (DGD) through Project
2.01 of the Third Framework Agreement between the Belgian DGD and ITM, Belgium;
the Flemish Interuniversity Council (VLIR-UOS); the Flemish Ministry of Sciences
(EWI; SOFI project IDIS and fellowship SVP); the Baillet Latour Fund (The Bacterial
Infections in the Tropics (BIT) research cluster at ITM Antwerp, Belgium); the FWO
Research Foundation—Flanders (travel grant to SVP.) and the Wellcome Trust. GD is
supported by The Wellcome Trust and the NIMR BRC AMR Theme at Cambridge.
Author contributions
Study design and oversight: S.V.P., J.J., G.D. and S.D. Data analysis: S.V.P., K.V., E.H., N.
W. and E.J.K. Isolate acquisition and processing and clinical data collection: J.J., B.B.,
L.K., L.M.K., M.-F.P., D.F., D.N. and O.L. Wet lab and infection experiments: D.P., T.dB.,
S.C., E.C., K.H., S.S. and E.L. Manuscript writing: S.V.P., J.J., G.D. and S.D. All authors
contributed to manuscript editing.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-11844-z.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Peer review information Nature Communications thanks the anonymous reviewers for
their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11844-z
12 NATURE COMMUNICATIONS |         (2019) 10:4280 | https://doi.org/10.1038/s41467-019-11844-z | www.nature.com/naturecommunications
